News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
279
Sources here
23
Companies here
13
Search results Stored financial headlines

Active search

279 matching headlines

Ticker or company: MIRMain company stories
Clear
Latest

Simply Wall Street Earnings

Will Mirum Pharmaceuticals' (MIRM) Widening Net Losses Test Its Growth-Focused Investment Narrative?

Mirum Pharmaceuticals reported a significant net loss for Q2 and H1 2026, with basic loss per share rising, which highlights increased costs relative to revenue. This widening loss intensifies focus on cash burn and funding risks, despite upcoming clinical and regulatory catalysts such as the FDA's Priority Review for zilurgisertib. Investors will need to assess whether the company's …

Main company 🇺🇸 United States
Read at Simply Wall Street
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
MarketBeat Earnings Main company 🇺🇸 United States

Wall Street Zen Downgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Sell

Wall Street Zen has downgraded Mirum Pharmaceuticals (NASDAQ:MIRM) from "hold" to "sell," despite the company reporting better-than-expected quarterly revenue of $176.24 million, a 37.9% increase year-over-year. The downgrade comes as the company missed earnings per share estimates, reporting a loss of $1.06 against a …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

SMG Stock Price and Chart — NYSE:SMG

This article provides a detailed overview of Scotts Miracle-Gro Company (SMG) stock, including its current price, market capitalization, dividend yield, and financial performance. It also features analyst ratings, seasonal trends, related ETF holdings, and a Q&A section addressing common investor questions about the company's …

SMG main company
Sharemaestro market context Trend signal active 52 weeks -0.7% SMG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Simply Wall Street Earnings Main company 🇺🇸 United States

Mirum Pharmaceuticals (MIRM) Stock Looks Fairly Valued After Recent News

Mirum Pharmaceuticals (MIRM) stock is currently considered fairly valued despite significant share price gains over the past five years. The company's P/S ratio of 10.4x is below the biotech industry average, suggesting it might still be on the inexpensive side. The future performance of …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Market source Earnings Main company 🇺🇸 United States

Why Mirum Pharmaceuticals (MIRM) Is Down 6.4% After Raising 2026 Sales Outlook Amid Wider Losses – And What's Next

Mirum Pharmaceuticals (MIRM) saw its stock drop 6.4% despite raising its 2026 net product sales guidance, due to reporting significantly wider net losses in the second quarter of 2026. The company highlighted progress with breakthrough therapy designation for volixibat and potential launch timing for …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Janus Henderson Group (MIRM) reports 5.9M Mirum Pharma shares under management

Janus Henderson Group Ltd., through its asset management subsidiaries, reported beneficial ownership of 5,909,184 shares of Mirum Pharmaceuticals, Inc. common stock, representing 9.7% of the class as of June 30, 2026. These shares are managed in client accounts (Managed Portfolios) where Janus Henderson holds …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026
The National Law Review Market update Main company 🇺🇸 United States

Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Mirum Pharmaceuticals, a rare disease company, announced it will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, in San Francisco. The presentation will be webcast live on Mirum's corporate website. The company is known for its approved products for …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Market update Main company 🇺🇸 United States

ScottsMiracle-Gro Brings America250’s “Our American Story” to ScottsMiracle-Gro Field

Scotts Miracle-Gro Company (The) Ohioans and Columbus Crew fans are invited to discover the national initiative and record their stories for historic preservation COLUMBUS, Ohio, Aug. 13, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn …

SMG main company
Sharemaestro market context Trend signal active 52 weeks -0.7% SMG stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) CFO Sells 6,001 Shares of Stock

Mirum Pharmaceuticals (NASDAQ:MIRM) CFO Eric Bjerkholt sold 6,001 shares of the company's stock for approximately $599,500, reducing his direct ownership by 14.17%. This transaction was conducted under a pre-arranged Rule 10b5-1 plan. Despite the insider sale and an earnings miss, analysts maintain a "Moderate …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026
The Globe and Mail Earnings Main company 🇺🇸 United States

Mirum Pharmaceuticals (MIRM) Q2 2026 Earnings Call Transcript

Mirum Pharmaceuticals (MIRM) reported strong Q2 2026 results with $176.2 million in net product sales, leading to an increased full-year guidance of $680 million to $700 million. The company is advancing its pipeline, including Zilurgisertib for FOP with a September PDUFA date, and addressing …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Mirum Pharmaceuticals (MIRM) CFO sells 6,001 shares in Rule 10b5-1 trade

Mirum Pharmaceuticals' CFO, Eric Bjerkholt, sold 6,001 shares of common stock on August 11, 2026, at a weighted average price of $99.90 per share. This transaction was conducted under a Rule 10b5-1 trading plan established on March 9, 2026. Following the sale, Bjerkholt beneficially …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketScreener España Market update Main company 🇦🇷 Argentina

Mirgor Sociedad Anónima, Comercial, Industrial, Financiera, Inmobiliaria y Agropecuaria presenta sus resultados del segundo trimestre y del primer semestre de 2026

MIRG main company
Sharemaestro market context Price below Trend Line 52 weeks -92.1% · Next-week setup negative 38.2% MIRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Earnings Main company 🇺🇸 United States

Mirum Pharmaceuticals CEO Christopher Peetz sells $1.98 million in shares

Mirum Pharmaceuticals CEO Christopher Peetz sold 20,000 shares of the company's common stock for approximately $1.98 million under a pre-arranged trading plan. Concurrently, he acquired 20,000 shares through the exercise of employee stock options for $58,720. Despite a recent stock pullback and an "overvalued" …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Mirum Pharmaceuticals (NASDAQ:MIRM) CEO Christopher Peetz Sells 20,000 Shares of Stock

Mirum Pharmaceuticals CEO Christopher Peetz sold 20,000 shares of the company's stock for approximately $1.98 million on August 10th, 2026, under a pre-arranged Rule 10b5-1 trading plan. This transaction reduced his direct ownership by 9.33% to 194,309 shares. Despite Mirum missing analysts' EPS estimates …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Mirum Pharmaceuticals (MIRM) CEO trades 20,000 shares after option exercise under 10b5-1 plan

Mirum Pharmaceuticals, Inc. CEO Christopher Peetz exercised an employee stock option for 20,000 shares at $2.936 per share and subsequently sold all 20,000 shares in three tranches at weighted average prices between $98.51 and $100.14. These transactions, which occurred on August 10, 2026, were …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

MIRM (MIRM) insider files to sell 6,001 shares after recent stock sales

An insider at Mirum Pharmaceuticals (MIRM), Eric Bjerkh olt, has filed a notice to sell 6,001 shares of common stock with an aggregate market value of $599,509.50. This proposed sale follows two previous sales by the same insider within the last three months, totaling …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context